ÁÖ½Äȸ»ç °æ¿¬ÆÄÆ®³Ê½º

¸ðÁýºÎ¹® ¹× ÀÚ°Ý¿ä°Ç

´ã´ç¾÷¹« ÀÚ°Ý¿ä°Ç Àοø

[´ã´ç¾÷¹«]

¤ý ±Û·Î¹ú Á¦¾à»ç¿Í Çù¾÷, ÆÄÆ®³Ê½± °ü·Ã Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× °ü¸® (project management)
¤ý Á¦¾à»ç¿ÍÀÇ Çù¾÷ (collaboration) ¹× °è¾à (Licensing)ÀÇ »ç¾÷°³¹ß(business development) ¹× ÁøÇà
¤ý Bio conference Âü¿© ¹× ±â¼ú ¼Ò°³ ¹ÌÆÃ ÁøÇà (¹ÌÆÃ ÈÄ follow-up)
¤ý »õ·Î¿î »ç¾÷ ÆÄÆ®³Ê»ç ¹ß±¼ ¾÷¹«
¤ý ´ç»ç ÆÄÀÌÇÁ¶óÀÎ Æ÷Æ®Æú¸®¿À Á¤¸®/°ü¸®


[±Ù¹«ºÎ¼­ ¹× Á÷±Þ/Á÷Ã¥]

    ±Ù¹«ºÎ¼­: BD
    Á÷±Þ/Á÷Ã¥: ºÎÀå, ÀÌ»ç, ÆÀÀå

[ÀÚ°Ý¿ä°Ç]

ÀÚ°Ý¿ä°Ç
¤ýÇз : ÇлçÀÌ»ó(¹ÙÀÌ¿À ¹× ¾àÇÐ µî °ü·ÃÇаú Àü°ø)
¤ýLicense in & Out À¯°æÇèÀÚ
¤ý»ç¾÷ °³¹ß °ü·Ã À¯°æÇèÀÚ
¤ý¿µ¾î´ÉÅëÀÚ

¿ì´ë»çÇ×
¤ýÇØ¿Ü°æÇè ¿ì´ë
¤ý±Û·Î¹ú Big Pharma¿ÍÀÇ NetworkIng ¹× ±¹³» Á¦¾àȸ»ç¿ÍÀÇ Networking

0 ¸í

±Ù¹«Á¶°Ç

  • °í¿ëÇüÅÂ: Á¤±ÔÁ÷(¼ö½À±â°£3°³¿ù)
  • ±Ù¹«ºÎ¼­: BD
  • ±Þ¿©Á¶°Ç: ¿¬ºÀ ÇùÀÇ ÈÄ °áÁ¤

ÀüÇü´Ü°è ¹× Á¦Ãâ¼­·ù

  • ÀüÇü´Ü°è: ¼­·ùÀüÇü > ¸éÁ¢ÁøÇà > ÃÖÁ¾½É»ç > ÃÖÁ¾ÇÕ°Ý
  • Ãß°¡ Á¦Ãâ¼­·ù
    À̷¼­, ÀÚ±â¼Ò°³¼­

Á¢¼ö¹æ¹ý

ä¿ë½Ã

  • Á¢¼ö¹æ¹ý: ÀÎÅ©·çÆ® ä¿ë½Ã½ºÅÛ, À̸ÞÀÏ
  • Á¢¼ö¾ç½Ä: ÀÎÅ©·çÆ® À̷¼­

±âŸ À¯ÀÇ»çÇ×

  • ÀÔ»çÁö¿ø¼­ ¹× Á¦Ãâ¼­·ù¿¡ ÇãÀ§»ç½ÇÀÌ ÀÖÀ» °æ¿ì ä¿ëÀÌ Ãë¼ÒµÉ ¼ö ÀÖ½À´Ï´Ù.

00